KYMRKymera Therapeutics, Inc.

$125.37

Who owns KYMR

254 institutions reported holding KYMR for 2026Q1, together 99% of the company, more than the 251 a quarter earlier.

254

Institutions reporting a position · as of 2026Q1 · up from 251 the quarter before

Shares held by institutions
96.3M

Shares held by institutions · 99% of the company · long US equity positions only, as reported on Form 13F

Reported value
$8.01B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
41%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
23
New positions
36
Positions exited
39
Added to
89
Reduced
70
Top 10 holdersof the company
66%
Institutional ownership by quarter, 2020Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q125496.3M$8.01B
2025Q425189.9M$6.99B
2025Q320780.9M$4.58B
2025Q220878.8M$3.44B
2025Q116872.8M$1.99B
2024Q417771.5M$2.88B
2024Q317368.9M$3.26B
2024Q215567.3M$2.01B
2024Q116367.2M$2.70B
2023Q413660.5M$1.54B
2023Q312057.4M$797M
2023Q212858.4M$1.34B
2023Q112656.9M$1.68B
2022Q411956.1M$1.40B
2022Q312552.8M$1.15B
2022Q29849.4M$973M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC11.7M12%$974M
BAKER BROS. ADVISORS LP8.7M8.9%$721M
Avoro Capital Advisors LLC7.5M7.7%$623M
VANGUARD GROUP INC6.3M6.4%$522M
PRICE T ROWE ASSOCIATES INC /MD/6.1M6.2%$505M
BVF INC/IL5.5M5.6%$458M
T. Rowe Price Investment Management, Inc.5.5M5.6%$455M
BlackRock Inc.5.1M5.2%$422M
Atlas Venture Life Science Advisors, LLC4.6M4.7%$381M
WELLINGTON MANAGEMENT GROUP LLP3.9M4.0%$324M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…